Metoprolol Succinate: Clinical Trials

2 trials of Metoprolol Succinate, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2

Follow Metoprolol Succinate: new trials by email Literature Review of Metoprolol Succinate trials Research Report on Metoprolol Succinate

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Effect of Metoprolol in Patients With Hypertrophic Obstructive Cardiomyopathy.
Metoprolol Succinate, Placebo oral capsule - Hypertrophic Cardiomyopathy
Phase 2CompletedSteen Hvitfeldt Poulsen302018-05-012021-03-29
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
bucindolol hydrochloride, metoprolol succinate, Placebo oral capsule - Current or Recent History of Atrial Fibrillation
Phase 2CompletedARCA Biopharma, Inc.2672014-04-012022-09-26

Conditions studied

Atrial Fibrillation (1)  ·  Atrial Flutter (1)  ·  Cardiomyopathy, Hypertrophic (1)  ·  Cardiovascular Diseases (1)  ·  Heart Diseases (1)  ·  Heart Failure (1)  ·  Ventricular Outflow Obstruction (1)

Sponsors

ARCA Biopharma, Inc. (1)  ·  Steen Hvitfeldt Poulsen (1)

Countries

Canada (1)  ·  Denmark (1)  ·  Hungary (1)  ·  Netherlands (1)  ·  Poland (1)  ·  Serbia (1)  ·  United States (1)

Top investigators

Jonathan Piccini, MD (1)  ·  Michael Bristow, MD,PhD (1)  ·  Morten Kvistholm Jensen, MD, PhD (1)  ·  Steen Hvitfeldt Poulsen, MD (1)  ·  Torsten Bloch Rasmussen, MD, PhD (1)

Results publications

PMID 29754666, PMID 34270905, PMID 34915981, PMID 35450573, PMID 39570238